Skip to main content

Substance Use Disorders Medication-Assisted Treatment

Tracking # 20-1268782

$15.00

There are no ratings for this course

Learn more
Educator EMEDED INC.
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

At the end of this activity, learners will be able to: 1. Define substance use disorder (SUD) and its various forms, including opioid use disorder (OUD), alcohol use disorder (AUD), and nicotine addiction. 2. Recognize the diagnostic criteria and clinical presentation of patients with SUD. 3. Describe the role of medication-assisted treatment (MAT) in treating substance use disorders, including its benefits and limitations when used with behavioral therapies. 4. Identify key medications used in MAT for SUD, including their mechanisms of action, indications, and contraindications. 5. Outline pharmacological agents used in the treatment of alcohol use disorder (AUD), such as topiramate, naltrexone, acamprosate, and disulfiram. 6. Explain the mechanisms of action, side effects, and patient education points for each drug used to treat AUD. 7. Identify the primary drugs used to manage opioid use disorder (OUD), including methadone, buprenorphine, and naltrexone. 8. Explain the pharmacokinetics, mechanisms of action, adverse effects, and special considerations for each medication used to treat OUD. 9. Understand the precautions, contraindications, and black box warnings associated with commonly used MAT drugs for SUD. 10. Learn about drug interactions, special patient populations (e.g., pregnant or lactating women, elderly patients), and monitoring requirements during MAT. 11. Develop skills to educate effectively and counsel patients on MAT therapies, addressing adherence, potential side effects, and lifestyle modifications. 12. Promote awareness of combining pharmacological treatment with psychosocial support and psychotherapy for optimal patient outcomes. 13. Identify common side effects and severe reactions associated with medications used in MAT for both AUD and OUD. 14. Develop strategies for managing side effects and ensuring patient safety during treatment. 15. Apply evidence-based guidelines for selecting and administering MAT in clinical practice for treating SUD. 16. Recognize the importance of a multidisciplinary approach involving medical, psychological, and social support in treating SUD.

Subject areas

This course counts toward the state boards and subject areas below.

Arkansas State Board of Nursing

Registered Nurse Practitioner

1h Practice-Focused Continuing Education

District of Columbia Board of Nursing

Nurse Practitioner

1h Pharmacology Component

Kansas State Board of Nursing

Nurse Practitioner

1h Approved CNE Related to the Advanced Practice Registered Nurse

New Hampshire Board of Nursing

Advanced Practice Registered Nurse

1h Pharmacology

North Dakota Board of Nursing

Advanced Practice Registered Nurse

1h CE Related to Nursing Practice

South Carolina Board of Nursing

Advanced Practice Registered Nurse

1h General

Disclosure statements

eMedEd ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, eMedEd identifies conflicts of interest with its instructors, planners, content managers, and other individuals who can control an activity's content. 


All faculty, planners, and/or content managers have nothing to disclose, nor do they have any vested interests or affiliations.